|
1
|
Castro D, Moreira M, Gouveia AM, Pozza DH
and De Mello RA: MicroRNAs in lung cancer. Oncotarget.
8:81679–81685. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu KL, Tsai YM, Lien CT, Kuo PL and Hung
AJ: The roles of MicroRNA in lung cancer. Int J Mol Sci.
20:E16112019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vannini I, Fanini F and Fabbri M:
MicroRNAs as lung cancer biomarkers and key players in lung
carcinogenesis. Clin Biochem. 46:918–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang WC, Liu J, Xu X and Wang G: The role
of microRNAs in lung cancer progression. Med Oncol. 30:6752013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Angulo M, Lecuona E and Sznajder JI: Role
of MicroRNAs in lung disease. Arch Bronconeumol (Spanish).
48:325–330. 2012. View Article : Google Scholar
|
|
7
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alipoor SD, Adcock IM, Garssen J, Mortaz
E, Varahram M, Mirsaeidi M and Velayati A: The roles of miRNAs as
potential biomarkers in lung diseases. Eur J Pharmacol.
791:395–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guz M, Rivero-Muller A, Okon E,
Stenzel-Bembenek A, Polberg K, Slomka M and Stepulak A:
MicroRNAs-role in lung cancer. Dis Markers. 2014:2181692014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kang SM and Lee HJ: MicroRNAs in human
lung cancer. Exp Biol Med (Maywood). 239:1505–1513. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu SG, Chang TH, Liu YN and Shih JY:
MicroRNA in lung cancer metastasis. Cancers (Basl). 11:E2652019.
View Article : Google Scholar
|
|
12
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen J, Liu Z, Todd NW, Zhang H, Liao J,
Yu L, Guarnera MA, Li R, Cai L, Zhan M and Jiang F: Diagnosis of
lung cancer in individuals with solitary pulmonary nodules by
plasma microRNA biomarkers. BMC Cancer. 11:3742011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Zhu X, Shou T, Yang L, Cheng X, Wang
J, Deng L and Zheng Y: MicroRNA-28 promotes cell proliferation and
invasion in gastric cancer via the PTEN/PI3K/AKT signalling
pathway. Mol Med Rep. 17:4003–4010. 2018.PubMed/NCBI
|
|
15
|
Xu J, Jiang N, Shi H, Zhao S, Yao S and
Shen H: miR-28-5p promotes the development and progression of
ovarian cancer through inhibition of N4BP1. Int J Oncol. Mar
16–2017.(Epub ahead of print). View Article : Google Scholar
|
|
16
|
Schneider C, Setty M, Holmes AB, Maute RL,
Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R and Basso K:
MicroRNA 28 controls cell proliferation and is down-regulated in
B-cell lymphomas. Proc Natl Acad Sci USA. 111:8185–8190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu W, He K, Guo Q, Chen J, Zhang M, Huang
K, Yang D, Wu L, Deng Y, Luo X, et al: SSRP1 promotes colorectal
cancer progression and is negatively regulated by miR-28-5p. J Cell
Mol Med. 23:3118–3129. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z,
Cao Y, Fan J, Huang XW and Zhou J: miR-28-5p-IL-34-macrophage
feedback loop modulates hepatocellular carcinoma metastasis.
Hepatology. 63:1560–1575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Wu C, Yang Q, Ding M, Zhong J,
Zhang CY, Ge J, Wang J and Zhang C: miR-28-5p acts as a tumor
suppressor in renal cell carcinoma for multiple antitumor effects
by targeting RAP1B. Oncotarget. 7:73888–73902. 2016.PubMed/NCBI
|
|
20
|
Nicholson AG, Chansky K, Crowley J,
Beyruti R, Kubota K, Turrisi A, Eberhardt WE and van Meerbeeck J;
Staging and Prognostic Factors Committee, Advisory Boards, and
Participating Institutions; Staging and Prognostic Factors
Committee Advisory Boards and Participating Institutions, . The
international association for the study of lung cancer lung cancer
staging project: Proposals for the revision of the clinical and
pathologic staging of small cell lung cancer in the forthcoming
eighth edition of the TNM classification for lung cancer. J
Thoracic Oncol. 11:300–311. 2016. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896.e9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Wen W, Shan X, Qian J, Li H, Jiang
T, Wang W, Cheng W, Wang F, Qi L, et al: MiR-28-3p as a potential
plasma marker in diagnosis of pulmonary embolism. Thromb Res.
138:91–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang YQ, Tian T, Zhu HY, Liang JH, Wu W,
Wu JZ, Xia Y, Wang L, Fan L, Li JY and Xu W: NDRG2 mRNA levels and
miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC
Cancer. 18:10092018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Girardot M, Pecquet C, Boukour S, Knoops
L, Ferrant A, Vainchenker W, Giraudier S and Constantinescu SN:
miR-28 is a thrombopoietin receptor targeting microRNA detected in
a fraction of myeloproliferative neoplasm patient platelets. Blood.
116:437–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang QZ, Xu W, Habib N and Xu R: Potential
uses of microRNA in lung cancer diagnosis, prognosis, and therapy.
Curr Cancer Drug Targets. 9:572–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hopkins BD and Parsons RE: Molecular
pathways: Intercellular PTEN and the potential of PTEN restoration
therapy. Clin Cancer Res. 20:5379–5383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zaman MS, Thamminana S, Shahryari V,
Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora
S, et al: Inhibition of PTEN gene expression by oncogenic
miR-23b-3p in renal cancer. PLoS One. 7:e502032012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ
and Lu NH: Reduced expression of PTEN and increased PTEN
phosphorylation at residue Ser380 in gastric cancer tissues: A
novel mechanism of PTEN inactivation. Clin Res Hepatol
Gastroenterol. 37:72–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 are onco-miRs
that target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
31
|
Zhang WL and Zhang JH: miR-181c promotes
proliferation via suppressing PTEN expression in inflammatory
breast cancer. Int J Oncol. 46:2011–2020. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou XP, Gimm O, Hampel H, Niemann T,
Walker MJ and Eng C: Epigenetic PTEN silencing in malignant
melanomas without PTEN mutation. Am J Pathol. 157:1123–1128. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li X, Wang HL, Peng X, Zhou HF and Wang X:
miR-1297 mediates PTEN expression and contributes to cell
progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Q, Lu RL, Li JX and Rong LJ: MiR-200a
and miR-200b target PTEN to regulate the endometrial cancer cell
growth in vitro. Asian Pac J Trop Med. 10:498–502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei H, Cui R, Bahr J, Zanesi N, Luo Z,
Meng W, Liang G and Croce CM: miR-130a deregulates PTEN and
stimulates tumor growth. Cancer Res. 77:6168–6178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li B and Sun H: MiR-26a promotes neurite
outgrowth by repressing PTEN expression. Mol Med Rep. 8:676–680.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Y, Luo LH, Li S and Yang C: miR-17
inhibitor suppressed osteosarcoma tumor growth and metastasis via
increasing PTEN expression. Biochem Biophys Res Commun.
444:230–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
